VJOncology is committed to improving our service to you

ESMO 2020 | Horizon scanning in GU cancer

VJOncology is committed to improving our service to you

Petros Grivas

Petros Grivas, MD, PhD, Seattle Cancer Care Alliance, Seattle, WA, discusses what’s coming for the treatment of genitourinary (GU) cancer in the next 12 months. Dr. Grivas predicts that the future will see more combinations and biomarkers, as currently this field does not use many biomarkers for patient selection. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter